VANCOUVER, Nov. 2, 2018 /CNW/ - Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF) (the "Company" or "Koios"), is pleased to announce that the Company's common shares have been made eligible with the Depository Trust Company (the "DTC").
The DTC is a subsidiary of the Depository Trust & Clearing Corporation (DTCC) and manages the electronic clearing and settlement of publicly traded companies. Securities that are eligible to be electronically cleared and settled through the DTC are considered DTC eligible. This electronic method of clearing securities speeds up the receipt of stock and cash, and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms by coming into compliance with their requirements.
Being DTC eligible is expected to greatly simplify the process of trading and exchange of the Company's common shares on the OTC Market.
The Company announces that it has entered into an investor relations consulting agreement (the "Midam Agreement") with Midam Ventures, LLC ("Midam"). The term of the Midam Agreement commenced on October 25, 2018 and ends on December 25, 2018, unless otherwise terminated as set forth in the Midam Agreement. Pursuant to the Midam Agreement, Midam will provide various business advisory, consulting and investor relations services to the Company in exchange for aggregate consulting fees of US$150,000, to be paid in two monthly payments of US$75,000.
The Company also announces that it has entered into an investor relations consulting agreement (the "Stonebridge Agreement") with Stonebridge Partners, LLC ("Stonebridge"). The term of the Stonebridge Agreement commenced on October 12, 2018 and ends on April 12, 2019. Pursuant to the Stonebridge Agreement, Stonebridge will provide various consulting and investor relations services to the Company in exchange for aggregate consulting fees of US$60,000.
Each of Midam and Stonebridge has filed a CSE Form 3 – Personal Information Form with the Canadian Securities Exchange.
About the Company's Business
The Company is an emerging functional beverage company which has an available distribution network of more than 2,000 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well. Koios is also the sole owner of Cannavated Beverage Corp., a subsidiary that develops beverage products and formulas for the growing cannabis market. Through its agreement with Keef Brands, the largest producer of cannabis beverages in North America, Cannavated enjoys distribution throughout the State of Colorado and is preparing for distribution in additional US states where cannabis use is legal.
Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants. Koios products can enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity. Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain.
Koios is one of the only drinks in the world to infuse its products with MCT oil. MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity. For more information, please visit our website: www.mentaltitan.com.
On behalf of the Board of Directors of the Company.
KOIOS BEVERAGE CORP.
Chris Miller, CEO and Director
This news release contains forward-looking statements. All statements, other than statements of historical fact that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements in this news release include statements regarding the benefits of DTC eligibility for the Company's shares and the Company's plans for distribution in additional US states where cannabis use is legal. The forward-looking statements reflect management's current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements. Although the Company believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to their inherent uncertainty. Factors that could cause actual results or events to differ materially from current expectations include general market conditions and other factors beyond the control of the Company. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.
Koios has not conducted any scientific studies on the effects of Koios' products which have been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking Koios' products will vary from person to person. No claims or guarantees can be made as to the effects of Koios' products on an individual's health and wellbeing.
SOURCE Koios Beverage Corp.
For further information: 604-283-1722